Approximately 1.5 million Americans (and 5 million people worldwide) have a form of lupus. Systemic lupus in America accounts ...

What makes love after lupus different is that it requires that one be willing to adapt to the challenges of this chronic ...

Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...

Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active L ...

Lupus, also known as Systemic Lupus Erythematosus (SLE), is a chronic autoimmune disease where the body's immune system ...

You feel like you have the flu, but you're not getting better Fever, chills, muscle aches and sleepiness are all classic ...

A new study identifies eight domains of active systemic #lupus erythematosus for defining meaningful treatment response in ...

WILLOW is a global, multicenter, randomized, placebo-controlled Phase 2 study evaluating three doses of enpatoran taken twice daily (25 mg, 50 mg and 100 mg) versus placebo plus standard of care (SoC) ...

Join Drs Maureen McMahon and Karen Costenbader as they explore how diet, pollution, infections, and lifestyle factors influence lupus risk and what patients can do about it.

Despite Merck KGaA’s lupus drug failing to prove itself against one form of the autoimmune disease, the German drugmaker has ...

Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus rash, showing clinically meaningful ...

Investigators assessed the frequency of lupus flares in patients with kidney failure undergoing dialysis or with a kidney transplant.